RNAi as New Class of Nanomedicines - Harnessing Biomaterials in Nanomedicine: Preparation, Toxicity, and Applications - page 195

virus type 1 inhibition in primary macrophages, J Virol . 77 : pp. 7174-
7181.
136. Song, E., S.K. Lee, J. Wang, N. Ince, N. Ouyang, J. Min, J. Chen, P. Shankar,
and J. Lieberman (2003). RNA interference targeting Fas protects mice
from fulminant hepatitis, Nat Med . 9 : pp. 347-351.
137. Song, E., P. Zhu, S.K. Lee, D. Chowdhury, S. Kussman, D.M. Dykxhoorn, Y.
Feng, D. Palliser, D.B. Weiner, P. Shankar, W.A. Marasco, and J. Lieberman
(2005). Antibody mediated in vivo delivery of small interfering RNAs
via cell-surface receptors, Nat Biotechnol . 23 : pp. 709-717.
138. Soutschek, J., A. Akinc, B. Bramlage, K. Charisse, R. Constien, M.
Donoghue, S. Elbashir, A. Geick, P. Hadwiger, J. Harborth, M. John,
V. Kesavan, G. Lavine, R.K. Pandey, T. Racie, K.G. Rajeev, I. Rohl, I.
Toudjarska, G. Wang, S. Wuschko, D. Bumcrot, V. Koteliansky, S. Limmer,
M. Manoharan, and H.P. Vornlocher (2004). Therapeutic silencing of
an endogenous gene by systemic administration of modified siRNAs,
Nature . 432 : pp. 173-178.
139. Subramanya, S., S.S. Kim, S. Abraham, J. Yao, M. Kumar, P. Kumar, V.
Haridas, S.K. Lee, L.D. Shultz, D. Greiner, M. N, and P. Shankar (2010).
Targeted delivery of small interfering RNA to human dendritic cells
to suppress dengue virus infection and associated proinflammatory
cytokine production, J Virol . 84 : pp. 2490-2501.
140. Takanashi, M., K. Oikawa, K. Sudo, M. Tanaka, K. Fujita, A. Ishikawa,
S. Nakae, R.L. Kaspar, M. Matsuzaki, M. Kudo, and M. Kuroda (2009).
Therapeutic silencing of an endogenous gene by siRNA cream in an
arthritis model mouse, Gene Ther . 16 : pp. 982-989.
141. Tiemann, K., and J.J. Rossi (2009). RNAi-based therapeutics — current
status, challenges and prospects, EMBO Mol Med . 1 : pp. 142-151.
142. Tuschl, T., P.D. Zamore, R. Lehmann, D.P. Bartel, and P.A. Sharp (1999).
Targeted mRNA degradation by double-stranded RNA in vitro , Genes
Dev . 13 : pp. 3191-3197.
143. Umbach, J.L., and B.R. Cullen (2009). The role of RNAi and microRNAs
in animal virus replication and antiviral immunity, Genes Dev . 23 : pp.
1151-1164.
144. Urban-Klein, B., S. Werth, S. Abuharbeid, F. Czubayko, and A. Aigner
(2005). RNAi-mediated gene-targeting through systemic application
of polyethylenimine (PEI)-complexed siRNA in vivo , Gene Ther. 12 : pp.
461-466.
145. Vaishnaw, A.K., J. Gollob, C. Gamba-Vitalo, R. Hutabarat, D. Sah, R.
Meyers, T. de Fougerolles, and J. Maraganore (2010) A status report on
RNAi therapeutics, Silence . 1 : pp. 14.